Method for assaying 3,5-substituted oxazolidones compound content

A technology of oxazolidinone and determination method, which is applied in the direction of material analysis by observing the influence on chemical indicators, testing of pharmaceutical preparations, and analysis by making materials undergo chemical reactions, etc.
CN101021487AInactive Publication Date: 2007-08-22SICHUAN BEILIKE BIOTECH LIABILITY

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
SICHUAN BEILIKE BIOTECH LIABILITY
Publication Date
2007-08-22
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The present invention provides a method for measuring 3, 5-substituted oxazolidone compound content, it is non-water detection method and includes: dissolving the sample by adding acid; adding crystal violet instruction liquid to the dissolved solution; titrating perchloric acid titrating solution to the solution till the solution becomes blue-green; and calculating the content of the sample. The method is convenient in the operation for the content measurement for chemical material medicine and content measurement for comparison sample, has accurate measuring result, and is simple in execution.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention provides a method for determining the content of 3,5-substituted oxazolidinone compounds, which is a non-aqueous titration method. The method is easy to operate in the content determination of chemical raw materials and reference substances. The result is accurate and easy to operate. Background technique

[0002] Antimicrobial resistance is a major problem facing the world today. Since the 1980s, multidrug-resistant gram-positive bacteria have become the main pathogens of hospital-acquired pneumonia. At present, the treatment of Gram-positive bacterial infections is mostly caused by drug-resistant bacteria, so that there are very few therapeutic drugs available for clinical use, which has become a major clinical challenge. Staphylococci can acquire multidrug resistance, especially in nosocomial infections, but also in community-acquired infections. The drug resistance mechanism of pathogenic bacteria is also constantly evolving. Repor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More